SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending sharply upward following a recent analyst upgrade and significant price target, which is energizing discussions around its potential in the burgeoning commercial space sector. This momentum is further fueled by strong anticipation of an imminent NASA Lunar Terrain Vehicle contract award, leading to widespread speculation about a potential short squeeze. The community is actively debating the stock's perceived undervaluation compared to industry peers and its capacity for sustained growth.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp (CCL) is trending due to the highly anticipated reinstatement of its quarterly dividend, coupled with a full-year report detailing record operational performance and investment-grade leverage metrics. The community is overwhelmingly bullish, celebrating this significant turning point as a strong indicator of renewed financial health and a robust outlook for the cruise sector. Despite initial price fluctuations, many investors view this as a clear sign of the company's return to strength and market leadership.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending lower following its recent earnings report, despite beating revenue and EPS estimates. The significant decline is driven by investor concerns over slumping sales in China, reduced profit margins, and the impact of tariffs. The community is actively debating whether the sell-off is an overreaction or a sign of deeper fundamental issues, with many citing market share erosion to competitors and questioning leadership's strategy.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following its announcement of joining the U.S. Department of Energy's Genesis Mission, positioning it as a key AI infrastructure provider for government and research. This partnership is fueling strong bullish sentiment within the community, with many anticipating significant future contracts and a potential short squeeze, while others remain wary of insider selling and previous debt-related concerns. The broader AI sector's performance and recent analyst upgrades further contribute to the lively discussion around its immediate trajectory.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following a significant $805 million government contract award for space vehicles, signaling strong demand for its national security capabilities. This substantial agreement, alongside the successful early completion of a U.S. Space Force mission, has ignited community discussions about RKLB's growth trajectory and the potential of its upcoming Neutron rocket. While many are bullish on its position in the expanding space and defense sector, some investors are also noting recent insider selling.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is actively discussed amidst investor apprehension regarding the long-term disruptive potential of autonomous vehicles from competitors like Waymo and Tesla, alongside concerns from an expanded FTC lawsuit. Despite these pressures, the community highlights Uber's strong financial performance, global platform leadership, and strategic autonomous partnerships as reasons for optimism, with many viewing the current price as a significant buying opportunity.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is trending after a robust Q2 earnings beat and a raised fiscal 2026 outlook, fueled by successful cost-cutting initiatives and improved package volumes. Community sentiment is mixed, with bulls celebrating the strong results and analyst upgrades, while skeptics point to ongoing concerns regarding freight operations, global trade headwinds, and the potential for a "sell the news" reaction. As a key transport bellwether, its performance is closely watched for insights into broader logistics sector health.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending following a substantial 10-year colocation agreement for its NC-1 AI data center campus, providing significant long-term revenue visibility. This major deal for AI infrastructure capacity is driving considerable community discussion, with investors highlighting the company's position in a rapidly expanding sector amidst high demand for compute power. Market participants are anticipating enhanced growth and potential for notable stock movement.

Starfighters Space Inc

Starfighters Space Inc (FJET) is trending due to its recent IPO, which saw its shares experience significant upward movement, largely attributed to its unique position as the sole commercial entity operating sustained Mach 2 supersonic flights from NASA's Kennedy Space Center. The community is actively discussing the stock's high volatility and trading halts, with many touting its potential as a groundbreaking aerospace player, though some caution about its microcap status and perceived lack of detailed financial transparency.

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

Amicus Therapeutics Inc

Amicus Therapeutics (FOLD) is actively discussed due to BioMarin Pharmaceutical's announced acquisition of the company for $14.50 per share in cash. This buyout is fueling significant community conversation, with traders celebrating the immediate upside and debating the valuation, while also sparking speculation on which other rare disease biotechs could be next in a consolidating market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Moderate Buy" from Brokerages

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat...

Niagen Bioscience (NASDAQ:NAGE) CFO Acquires 4,465 Shares

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) CFO Ozan Pamir bought 4,465 shares of the stock in a transaction dated Friday, November 14th. The stock was bought at an average price of $6.81...

Niagen Bioscience Launches Tru Niagen Beauty The First NAD+ Skincare Supplement in the U.S. Featuring Niagen (Patented Nicotinamide Riboside)

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen Beauty...

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the...

Q2 EPS Estimate for Niagen Bioscience Raised by Analyst

Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) - Research analysts at Roth Capital raised their Q2 2026 EPS estimates for shares of Niagen Bioscience in a research note issued to investors on...

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up After Better-Than-Expected Earnings

Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up on Earnings Beat...

Niagen Bioscience Announces $10 Million Share Repurchase Program

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has...

Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates

Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +150.00% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced financial results for the third quarter of 2025. Third Quarter 2025 Financial Highlights Compared to Prior Year Period Total net sales increased...

Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline

Recursion Pharmaceuticals (RXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.02	--	--	N/A
Q3 '25	$0.02	$0.05	185.71%	BEAT
Q2 '25	$0.01	$0.04	344.44%	BEAT
Q1 '25	--	$0.07	--	N/A

NAGE
Niagen Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest NAGE News

NAGENiagen Bioscience Inc.